Aligos Therapeutics (NASDAQ:ALGS) is set to give its latest quarterly earnings report on Tuesday, 2024-03-12. Here’s what investors need to know before the announcement.
Analysts estimate that Aligos Therapeutics will report an earnings per share (EPS) of $-0.27.
Aligos Therapeutics bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the …